Medicinal Products

Rivaroxaban Accord

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Rivaroxaban Accord
Active Substance rivaroksaban
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
ATC Code B01AF01
Marketing status stavljeno u promet
Shortage status nema nestašice
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals		 Vodič za liječnike s informacijama o primjeni rivaroksabana, verzija 1
Educational materials
for patients / caregivers		 Kartica s upozorenjima za bolesnika Rivaroksaban Accord

Packaging

Back

For Patients and Public

For Health Care Professionals

For Industry Representatives